187 related articles for article (PubMed ID: 18590472)
1. Efficacy and tolerability of pregabalin in partial epilepsy.
Beydoun A; Nasreddine W; Atweh S
Expert Rev Neurother; 2008 Jul; 8(7):1013-24. PubMed ID: 18590472
[TBL] [Abstract][Full Text] [Related]
2. Pharmacology and mechanism of action of pregabalin: the calcium channel alpha2-delta (alpha2-delta) subunit as a target for antiepileptic drug discovery.
Taylor CP; Angelotti T; Fauman E
Epilepsy Res; 2007 Feb; 73(2):137-50. PubMed ID: 17126531
[TBL] [Abstract][Full Text] [Related]
3. Pregabalin: a novel gamma-aminobutyric acid analogue in the treatment of neuropathic pain, partial-onset seizures, and anxiety disorders.
Tassone DM; Boyce E; Guyer J; Nuzum D
Clin Ther; 2007 Jan; 29(1):26-48. PubMed ID: 17379045
[TBL] [Abstract][Full Text] [Related]
4. [Clinical experiences with pregabalin in the treatment of focal epilepsies].
Gil-Nagel Rein A; Gómez-Alonso J
Rev Neurol; 2005 May 16-31; 40(10):609-13. PubMed ID: 15926135
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of two pregabalin regimens for add-on treatment of partial epilepsy.
Beydoun A; Uthman BM; Kugler AR; Greiner MJ; Knapp LE; Garofalo EA;
Neurology; 2005 Feb; 64(3):475-80. PubMed ID: 15699378
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic and pharmacodynamic profile of pregabalin and its role in the treatment of epilepsy.
Schulze-Bonhage A
Expert Opin Drug Metab Toxicol; 2013 Jan; 9(1):105-15. PubMed ID: 23205518
[TBL] [Abstract][Full Text] [Related]
7. Pregabalin add-on treatment in patients with partial seizures: a novel evaluation of flexible-dose and fixed-dose treatment in a double-blind, placebo-controlled study.
Elger CE; Brodie MJ; Anhut H; Lee CM; Barrett JA
Epilepsia; 2005 Dec; 46(12):1926-36. PubMed ID: 16393158
[TBL] [Abstract][Full Text] [Related]
8. Pregabalin pharmacology and its relevance to clinical practice.
Ben-Menachem E
Epilepsia; 2004; 45 Suppl 6():13-8. PubMed ID: 15315511
[TBL] [Abstract][Full Text] [Related]
9. Pregabalin: a new antiepileptic drug for refractory epilepsy.
Hamandi K; Sander JW
Seizure; 2006 Mar; 15(2):73-8. PubMed ID: 16413993
[TBL] [Abstract][Full Text] [Related]
10. Pregabalin drug interaction studies: lack of effect on the pharmacokinetics of carbamazepine, phenytoin, lamotrigine, and valproate in patients with partial epilepsy.
Brodie MJ; Wilson EA; Wesche DL; Alvey CW; Randinitis EJ; Posvar EL; Hounslow NJ; Bron NJ; Gibson GL; Bockbrader HN
Epilepsia; 2005 Sep; 46(9):1407-13. PubMed ID: 16146435
[TBL] [Abstract][Full Text] [Related]
11. The impact of background antiepileptic drugs on the efficacy and safety of pregabalin in treating partial-onset seizures: a post hoc analysis of combined clinical trials.
Tomson T; Almas M; Giordano S; Cabrera J
Epilepsy Res; 2011 Sep; 96(1-2):64-73. PubMed ID: 21624821
[TBL] [Abstract][Full Text] [Related]
12. Pregabalin: new drug. Very similar to gabapentin.
Prescrire Int; 2005 Dec; 14(80):203-6. PubMed ID: 16397976
[TBL] [Abstract][Full Text] [Related]
13. Pregabalin action at a model synapse: binding to presynaptic calcium channel alpha2-delta subunit reduces neurotransmission in mice.
Joshi I; Taylor CP
Eur J Pharmacol; 2006 Dec; 553(1-3):82-8. PubMed ID: 17064682
[TBL] [Abstract][Full Text] [Related]
14. Reduction of secondarily generalized tonic-clonic (SGTC) seizures with pregabalin.
Briggs DE; Lee CM; Spiegel K; French JA
Epilepsy Res; 2008 Nov; 82(1):86-92. PubMed ID: 18752932
[TBL] [Abstract][Full Text] [Related]
15. Long-term add-on pregabalin treatment in patients with partial-onset epilepsy: pooled analysis of open-label clinical trials.
Uthman BM; Bazil CW; Beydoun A; Schulze-Bonhage A; Benabou R; Whalen E; Emir B; Griesing T; Leon T
Epilepsia; 2010 Jun; 51(6):968-78. PubMed ID: 20345940
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of pregabalin versus lamotrigine in patients with newly diagnosed partial seizures: a phase 3, double-blind, randomised, parallel-group trial.
Kwan P; Brodie MJ; Kälviäinen R; Yurkewicz L; Weaver J; Knapp LE
Lancet Neurol; 2011 Oct; 10(10):881-90. PubMed ID: 21889410
[TBL] [Abstract][Full Text] [Related]
17. Activity profile of pregabalin in rodent models of epilepsy and ataxia.
Vartanian MG; Radulovic LL; Kinsora JJ; Serpa KA; Vergnes M; Bertram E; Taylor CP
Epilepsy Res; 2006 Mar; 68(3):189-205. PubMed ID: 16337109
[TBL] [Abstract][Full Text] [Related]
18. Add-on treatment with pregabalin for partial seizures with or without generalisation: pooled data analysis of four randomised placebo-controlled trials.
Gil-Nagel A; Zaccara G; Baldinetti F; Leon T
Seizure; 2009 Apr; 18(3):184-92. PubMed ID: 18951818
[TBL] [Abstract][Full Text] [Related]
19. Pregabalin: as adjunctive treatment of partial seizures.
Warner G; Figgitt DP
CNS Drugs; 2005; 19(3):265-72; discussion 273-4. PubMed ID: 15740180
[TBL] [Abstract][Full Text] [Related]
20. Erectile dysfunction associated with pregabalin add-on treatment in patients with partial seizures: five case reports.
Hitiris N; Barrett JA; Brodie MJ
Epilepsy Behav; 2006 Mar; 8(2):418-21. PubMed ID: 16446121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
